About

General information

"Cifra" Publishing House has been releasing scientific articles since 2012. Our journals accept papers in all scientific fields. Currently, the publishing house regularly issues 17 peer-reviewed scientific journals. The aim is to help authors share the results of their research with the widest possible range of readers.

We have developed a special publishing platform that makes the editorial process convenient and understandable, as well as allows formatting the texts of articles in accordance with the standards of leading foreign scientific journals.

We value the work of our reviewers, so we give the opportunity to publish reviews along with the articles. All articles and all tables, figures, and published reviews are assigned a DOI indexing.

It is important for us to increase the visibility of our authors and the citation of their scientific papers, so we send article metadata to leading bibliographic databases and libraries.

Five journals of the publishing house are included in the HAC. Most journals are indexed in Google Scholar and other repositories and libraries. 

In addition to the main databases, we focus on indexing journals in specialized databases such as GeoRef, MathNet, Agris, DOAJ, Chemical Abstracts and PubMed. 

Policies

1. Digital archiving policy

The information about all the articles published is archived in Russian Electronic Scientific Library (eLIBRARY.ru). The search tool is available on eLIBRARY.ru website and may be conducted by title, author, keywords, abstract, etc. on eLIBRARY.ru. The URLs to the full texts are available on the article’s page on eLIBRARY.ru. The full texts of the articles are also stored on our server and can be accessed through the search page https://cifra.science/en.

CC License type: Attribution 4.0 International (CC BY 4.0)

2. Open Access policy

The journal is an open-access journal which means that everybody can read, download, copy, distribute, print, search, or link to the full texts of these articles in accordance with CC License.
You are free to:

  • Share — copy and redistribute the material in any medium or format
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

License type: Attribution 4.0 International (CC BY 4.0).

«Attribution» («Атрибуция») 4.0 Всемирная (CC BY 4.0)

3. Deposit policy

The author can archive post-print (i.e. final draft post-refereeing) or publisher's version/PDF. 

4. Policies on Conflict of Interest, Human and Animal rights, and Informed Consent

4.1 Competing interests

The publisher requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read “The authors have declared that no competing interests exist.” The publisher may ask for further information relating to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.

Competing interests may be financial or non-financial. A competing interest exists when the authors’ interpretation of data or presentation of information may be influenced by their personal or financial relationships with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.

Financial competing interests include (but are not limited to):
– Receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
– Holding stocks or shares in an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
– Holding, or currently applying for, patents relating to the content of the manuscript.
– Receiving reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript.
– Non-financial competing interests
– Non-financial competing interests include (but are not limited to) political, personal, religious, ideological, academic, and intellectual competing interests. If, after reading these guidelines, you are unsure whether you have a competing interest, please contact the Editor.

Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should declare these as competing interests on submission. They should also adhere to the Good Publication Practice guidelines for pharmaceutical companies, which are designed to ensure that publications are produced in a responsible and ethical manner. The guidelines also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations, and communications companies. We will not publish advertorial content.

4.2. Human and animal rights

All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s)’ institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.

Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to Editors on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information.

If a study has not been submitted to an ethics committee prior to commencing, retrospective ethics approval usually cannot be obtained and it may not be possible to consider the manuscript for peer review. How to proceed in such cases is at the Editor(s)’ discretion.

Authors reporting the use of a new procedure or tool in a clinical setting, for example as a technical advance or case report, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient’s clinical need. Such justification is not required if the new procedure is already approved for clinical use at the authors’ institution. Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.

4.3. Informed consent

For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.

For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. If the participant has died, then consent for publication must be sought from the next of kin of the participant. This documentation must be made available to Editors on request and will be treated confidentially. In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of images may not be required. The final decision on whether consent to publish is required lies with the Editor.

Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.

A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption). The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.

For experimental studies involving client-owned animals, authors must also document informed consent from the client or owner and adherence to a high standard (best practice) of veterinary care.

Field studies and other non-experimental research on animals must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. A statement detailing compliance with relevant guidelines and/or appropriate permissions or licenses must be included in the manuscript. We recommend that authors comply with the Convention on the Trade in Endangered Species of Wild Fauna and Flora and the IUCN Policy Statement on Research Involving Species at Risk of Extinction.

Authors are strongly encouraged to conform to the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines, developed by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), for reporting animal studies.

For studies reporting livestock trials with production, health, and food-safety outcomes, authors are encouraged to adhere to the Reporting Guidelines for Randomized Controlled Trials in Livestock and Food Safety (REFLECT). 

5. Advertising Policies for web publications

Currently, Cifra LLC do not allow any advertisement as we follow the Golden Open Access model.

6. Compliance with ICMJE Recommendations

The journal fully complies with the ICMJE Recommendations.

7. Article Identification Policy

All the articles are assigned with DOI (Digital object identifier). DOIs are assigned through RADS.

8. Plagiarism check

All the articles received are checked for plagiarism.

9. Journal author rights 

All our journals are open access (OA) journals. For our journals to publish and disseminate research articles, we need authors' consent to publish their works. This is determined by a publishing agreement between the author and Cifra LLC. This agreement deals with the license of the right to publish to Cifra LLC and authors retain the rights to use and share their own published articles. Cifra LLC supports the need for authors to share, disseminate, and maximize the impact of their research, and these rights, in Cifra LLC are defined below:

Authors sign a non-exclusive license agreement, where authors have copyright but license non-exclusive rights in their article to the publisher. In this case, authors have the right to:

  • Share their article in the same ways permitted to third parties under the relevant user license (together with Personal Use rights), the end-user license, and a DOI link.
  • Retain patent, trademark, and other intellectual property rights (including raw research data).
  • Proper attribution and credit for the published work.

10. The process for handling cases requiring corrections, retractions, and editorial expressions of concern

In case of suspicion of a dishonest publication (duplicate publication, plagiarism, fabricated data, change of authorship, undisclosed conflict of interest, violation of ethical standards by reviewers or authors, complaints against editors, and other issues), the editorial board of the journal will follow the roadmap of the Publication Ethics Committee (http://publicationethics.org/resources/flowcharts). The editorial board will discuss the suspicious case and make a decision. The journal will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

Errata

Errata that were made while writing, typing, editing, or publishing (for example, a typo, a missing word or line, or an incorrectly labeled picture) of an article. Send corrections to the journal's email address.

Author corrections

If authors need to be added or removed, or the order of authorship changed, the respective author should contact the editors explaining the reason for such changes. When an author makes a change request, the editorial board convenes an ethics committee to determine if the change is appropriate. If a new author is to be added or an author is to be removed, it is the responsibility of the respective author to ensure that all interested authors are aware of and agree to the change in authorship.

Retractions

Retractions are published if serious errors or violations of ethics are made, which, for example, may cast doubt on the source of the data or the reliability of the results and conclusions of the article. To initiate a retraction, the author or other involved party needs to contact the editors of the journal via e-mail.

Peer review policy

1. All manuscripts submitted to our journals are subject to double-blind peer-review process.

2. The managing editor checks the article for compliance with the rules of styling and the scope of the journal. Then the article is sent for review to the external reviewer whose research interests are the closest to the issues covered in the article.

3. The reviewing period can vary depending on the specific situation, but shall not exceed 4 weeks.

4. The review addresses the following questions:

A) whether the content of the article corresponds to the title;

B) whether the article meets modern achievements of science;

C) whether the article could be understood by the reader from the point of view of style, language, form, clarity, graphics, tables, charts, formulas;

D) whether the article regards the previously published literature on this issue;

D) evaluation of the articles on the subject of borrowings and plagiarism;

E) outlining specific positive and negative sides of work, as well as suggestions for improvement of the article.

G) verdict about the possibility of publishing the article in the journal.

5. If the review contains recommendations on correction and revision of the article, the Executive Secretary of the journal sends the author the text of the review with a proposal to take them into account when preparing a new version of the article. The author can provide arguments to defend his/her point of view.  The modified (revised) article is sent for review.

6. The negative review with the reasons for refusal is sent to the author by e-mail.

7. In the case of a positive decision on the admission of the article for publication, the managing editor informs the author and indicates the date of publication. Review is sent to the author by e-mail.

8. The originals of reviews are kept in the Publisher's office for five years and can be provided to the competent authorities on request.

Contact details

Founder and publisher: Cifra LLC.

Address for correspondence: 620066, Sverdlovsk region, Ekaterinburg, st. Akademicheskaya, 11A, office 1.

Editorial phone number: +7-900-202-3909.

Email: support@system.cifra.science